Uniplan Investment Counsel, Inc. Calyxt, Inc. Transaction History

Uniplan Investment Counsel, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.91 $289,571 - $1.1 Million	-1,206,546 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $2.46 $12,524 - $30,206	12,279 Added 1.03%	1,206,546 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$2.06 - $4.05 $1.39 Million - $2.72 Million	672,714 Added 128.98%	1,194,267 $2.54 Million
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.08 $9,657 - $15,427	-3,037 Reduced 0.58%	521,553 $1.76 Million
Q2 2021 Aug 13, 2021	BUY	$3.83 - $6.31 $1.02 Million - $1.68 Million	266,383 Added 103.17%	524,590 $2.11 Million
Q1 2021 May 14, 2021	SELL	$4.25 - $12.01 $16,345 - $46,190	-3,846 Reduced 1.47%	258,207 $1.55 Million
Q4 2020 Feb 12, 2021	SELL	$3.21 - $5.68 $46,930 - $83,041	-14,620 Reduced 5.28%	262,053 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$4.37 - $7.66 $1.21 Million - $2.12 Million	276,673 New	276,673 $1.52 Million

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.